Edge Therapeutics (EDGE) Reports Q3 Loss of $7.08

Edge Therapeutics (NASDAQ: EDGE) reported Q3 EPS of ($7.08), versus ($2.30) reported last year.

For earnings history and earnings-related data on Edge Therapeutics (EDGE) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)